Screener
Bioventus BVS Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Bioventus’s reported figures.
The source filing: Bioventus’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:43 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001665988-26-000042
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|---|---|
| Net sales | $153,208 | $147,660 | $285,297 | $271,536 |
| Cost of sales (including depreciation and amortization of $9,893, $10,603, $19,980 and $20,868, respectively) | 47,542 | 45,570 | 88,862 | 86,390 |
| Gross profit | 105,666 | 102,090 | 196,435 | 185,146 |
| Selling, general and administrative expense | 82,740 | 79,110 | 161,065 | 152,612 |
| Research and development expense | 3,173 | 3,172 | 5,640 | 6,183 |
| Restructuring costs | (415) | — | 39 | — |
| Depreciation and amortization | 1,041 | 1,439 | 2,148 | 3,032 |
| Loss on disposals | — | 1 | — | 82 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bioventus's gross profit?
- Bioventus (BVS) reported gross profit of $105.67M in Q2 2026.
- How has Bioventus's gross profit changed year-over-year?
- Bioventus's gross profit increased by 3.5% year-over-year, from $102.09M to $105.67M.
- What is the long-term trend for Bioventus's gross profit?
- Over 4 years (2021 to 2025), Bioventus's gross profit has grown at a 6.4% compound annual growth rate (CAGR), from $302.71M to $388.16M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Bioventus's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude